A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-1)

Project: Research

Project Details

StatusActive
Effective start/end date10/02/26 → 9/02/31

Clinical Trial Phase

  • Phase III (a & b)